J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE572A01036
Key metrics
- Market Cap
- ₹38,793 Cr
- P/E Ratio
- 54.22
- EPS
- 44.56
- Book Value
- 259.05
- P/B Ratio
- 9.3
- ROE
- 17.06%
- ROCE
- 21.64%
- Debt / Equity
- 0
- Net Margin
- 17.41%
- Revenue Growth
- 5.55%
- Profit Growth
- 7.56%
- Dividend Yield
- 0.77%
- 52W High
- ₹2,525.50
- 52W Low
- ₹1,638.50
- Market Cap Band
- large cap
- Face Value
- 1
Ratios computed from the annual results period ending 2026-03-31.
About J. B. Chemicals & Pharmaceuticals Limited
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; and nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage forms, such as tablets, capsules, liquids, gels, lozenges, creams, injectables, powder, cold rubs, eye drops, and troches; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, the company offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners; and contract manufacturing services. It provides its products to gastroenterology, anti-infectives, wound care, neonatology and pediatrics, genecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India.
- Headquarters
- Mumbai, India
- Employees
- 5,602
- Promoter Holding
- 49.23%
The full J. B. Chemicals & Pharmaceuticals Limited analysis
Create a free account to open the complete JBCHEPHARM deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.